Skip to main content

GNTA · Genenta Science S.p.A. · Financials

Track GNTA — free
$0.68 -0.02 (-3.00%) At close · Nov 5
Market Cap
$47.49M
Shares
48.22M
Volume · Nov 5 155.3K Avg daily vol (3M) 84.87K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
-6.53M +26.7%
FY2025 Net Income FY2019–FY2025
Diluted EPS
-0.33 +32.7%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-6.87M -10.1%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
EUR 2.7M 4.81M 6.47M 5.34M 3.39M 4.69M 3.7M
EUR 3.9M 4.95M 5.26M 5.71M 2.3M 901.77K 921.52K
EUR 28.08K 44.52K 42.45K 6140 4889 1900 —
EUR 6.6M 9.76M 11.73M 11.04M 5.69M 5.59M 4.62M
EUR -6.6M -9.76M -11.73M -11.04M -5.69M -5.59M -4.62M
EUR 73.91K 851.82K 87.49K 2.57M 157.94K -1788 26.78K
EUR -6.53M -8.91M -11.65M -8.48M -5.53M -5.59M -4.6M
EUR -6.53M -8.91M -11.65M -8.48M -5.53M -5.59M -4.6M
EUR -6.45M -9.05M -11.45M -8.48M -5.53M -5.59M -4.6M
shares 19.71M 18.27M 18.22M 18.22M 15.08M — —
shares 19.71M 18.27M 18.22M 18.22M 15.08M — —
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent convertible debt 2025-12-31 EUR 7,603,000 20-F filed 2026-04-01
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1838716 CUSIP 36870W100 13F (30d) 4 filings 4 filers Visit website Investor relations